Page last updated: 2024-08-24

sertindole and Chronic Disease

sertindole has been researched along with Chronic Disease in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hansen, K; Lançon, C; Sapin, C; Toumi, M	1
Cai, ZJ; Hwang, JY; Kwon, JS; Mittoux, A; Ong, A; Su, TP	1
Daniel, DG; Kane, JM; Kashkin, KB; Mack, RJ; Sebree, TB; Tamminga, CA; Wallin, BA; Wozniak, PJ; Zimbroff, DL	1
Schooler, NR	1

Reviews

1 review(s) available for sertindole and Chronic Disease

Article	Year
New antipsychotic medications: strategies for evaluation and selected findings. Schizophrenia research, 1997, Oct-30, Volume: 27, Issue:2-3 Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Approval; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Placebos; Psychotic Disorders; Recurrence; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States; United States Food and Drug Administration	1997

Article

Year

New antipsychotic medications: strategies for evaluation and selected findings.

Schizophrenia research, 1997, Oct-30, Volume: 27, Issue:2-3

Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Approval; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Placebos; Psychotic Disorders; Recurrence; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States; United States Food and Drug Administration

1997

Trials

2 trial(s) available for sertindole and Chronic Disease

Article	Year
The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study. International clinical psychopharmacology, 2012, Volume: 27, Issue:6 Topics: Adolescent; Adult; Aged; Benzodiazepines; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imidazoles; Indoles; Male; Middle Aged; Olanzapine; Schizophrenia; Time Factors; Treatment Failure; Treatment Outcome; Young Adult	2012
Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. The American journal of psychiatry, 1997, Volume: 154, Issue:6 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitalization; Humans; Imidazoles; Indoles; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Treatment Outcome	1997

Article

Year

The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study.

International clinical psychopharmacology, 2012, Volume: 27, Issue:6

Topics: Adolescent; Adult; Aged; Benzodiazepines; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imidazoles; Indoles; Male; Middle Aged; Olanzapine; Schizophrenia; Time Factors; Treatment Failure; Treatment Outcome; Young Adult

2012

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.

The American journal of psychiatry, 1997, Volume: 154, Issue:6

Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitalization; Humans; Imidazoles; Indoles; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Treatment Outcome

1997

Other Studies

1 other study(ies) available for sertindole and Chronic Disease

Article	Year
The Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe. BMC psychiatry, 2008, Jul-18, Volume: 8 Topics: Adult; Antipsychotic Agents; Brain Diseases; Chronic Disease; Europe; Female; Humans; Imidazoles; Indoles; Long QT Syndrome; Male; Program Development; Prospective Studies; Psychotic Disorders; Retrospective Studies; Schizophrenia; Severity of Illness Index; Surveys and Questionnaires; Survival Rate	2008

Article

Year

The Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe.

BMC psychiatry, 2008, Jul-18, Volume: 8

Topics: Adult; Antipsychotic Agents; Brain Diseases; Chronic Disease; Europe; Female; Humans; Imidazoles; Indoles; Long QT Syndrome; Male; Program Development; Prospective Studies; Psychotic Disorders; Retrospective Studies; Schizophrenia; Severity of Illness Index; Surveys and Questionnaires; Survival Rate

2008